Prevalence of Frailty and Prefrailty in People With Human Immunodeficiency Virus Aged 50 or Older: A Systematic Review and Meta-Analysis

Yuji Yamada; Takaaki Kobayashi; Angela Condo; Aroonsiri Sangarlangkarn; Fred Ko; Yu Taniguchi; Gotaro Kojima

doi:10.1093/ofid/ofac129

Back

Prevalence of Frailty and Prefrailty in People With Human Immunodeficiency Virus Aged 50 or Older: A Systematic Review and Meta-Analysis

Journal article

Open access

Peer reviewed

Prevalence of Frailty and Prefrailty in People With Human Immunodeficiency Virus Aged 50 or Older: A Systematic Review and Meta-Analysis

Yuji Yamada, Takaaki Kobayashi, Angela Condo, Aroonsiri Sangarlangkarn, Fred Ko, Yu Taniguchi and Gotaro Kojima

Open forum infectious diseases, Vol.9(5), pp.ofac129-ofac129

05/01/2022

DOI: 10.1093/ofid/ofac129

PMCID: PMC8995074

PMID: 35415198

Files and links (1)

url

https://doi.org/10.1093/ofid/ofac129View

Published (Version of record) Open Access

Abstract

The studies identified by our systematic review demonstrated a wide range of frailty prevalence among people with HIV aged 50 or older. The meta-analysis showed the pooled prevalence of frailty and prefrailty in this population was 10.9% and 47.2%, respectively. Background With effective antiretroviral therapy, there is an emerging population of adults aged 50 years or older with human immunodeficiency virus (HIV). Frailty is an increasingly recognized clinical state of vulnerability associated with disability, hospitalization, and mortality. However, there is a paucity of large studies assessing its prevalence in people with HIV (PWH) aged 50 or older. Methods PubMed was systematically searched for studies published between January 2000 and August 2020 reporting the prevalence of frailty in PWH aged 50 or older. The pooled prevalence of frailty and prefrailty was synthesized using a random-effects meta-analysis. Results Of the 425 studies identified, 26 studies were included in the analysis, with a total of 6584 PWH aged 50 or older. The included studies were published between 2012 and 2020, and all studies used the Fried frailty phenotype to define frailty. The overall pooled prevalence of frailty and prefrailty was 10.9% (95% confidence interval [CI], 8.1%-14.2%) and 47.2% (95% CI, 40.1%-54.4%), respectively. A high degree of heterogeneity was observed (I-2 = 93.2%). In the subgroup analysis, HIV-related variables and other demographic variables were examined, and heterogeneity disappeared only in the group of a longer duration since HIV diagnosis (I-2 = 0%). Conclusions The pooled prevalence of frailty and prefrailty defined by the Fried frailty phenotype was assessed in PWH aged 50 or older. Findings from this study quantified the proportion of this specific population with this common geriatric syndrome. Future studies identifying effective strategies for frailty screening and intervention are required for this vulnerable population.

Immunology

Infectious Diseases

Life Sciences & Biomedicine

Microbiology

Science & Technology

Details

Title: Subtitle: Prevalence of Frailty and Prefrailty in People With Human Immunodeficiency Virus Aged 50 or Older: A Systematic Review and Meta-Analysis
Creators: Yuji Yamada - Icahn School of Medicine at Mount Sinai
Takaaki Kobayashi - University of Iowa
Angela Condo - Icahn School of Medicine at Mount Sinai
Aroonsiri Sangarlangkarn - Temple University
Fred Ko - Icahn School of Medicine at Mount Sinai
Yu Taniguchi - National Institute for Environmental Studies
Gotaro Kojima - AGA (Sweden)
Resource Type: Journal article
Publication Details: Open forum infectious diseases, Vol.9(5), pp.ofac129-ofac129
DOI: 10.1093/ofid/ofac129
PMID: 35415198
PMCID: PMC8995074
NLM abbreviation: Open Forum Infect Dis
ISSN: 2328-8957
eISSN: 2328-8957
Publisher: Oxford University Press
Number of pages: 10
Language: English
Date published: 05/01/2022
Academic Unit: Infectious Diseases; Internal Medicine
Record Identifier: 9984359859402771

Metrics

38 Record Views

40 Times Cited - Web of Science